دورية أكاديمية
أعرض في EDS

Bilosomes as Nanocarriers for the Drug and Vaccine Delivery against Gastrointestinal Infections: Opportunities and Challenges.

التفاصيل البيبلوغرافية
العنوان: Bilosomes as Nanocarriers for the Drug and Vaccine Delivery against Gastrointestinal Infections: Opportunities and Challenges.
المؤلفون: Zarenezhad E; Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa P.O. Box 7461686688, Iran., Marzi M; Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa P.O. Box 7461686688, Iran., Abdulabbas HT; Department of Medical Microbiology, Medical College, Al Muthanna University, Al Muthanna P.O. Box 07835544777, Iraq., Jasim SA; College of Applied Science, University of Fallujah, Fallujah, Anbar 31002, Iraq., Kouhpayeh SA; Department of Pharmacology, Faculty of Medicine, Fasa University of Medical Sciences, Fasa P.O. Box 7461686688, Iran., Barbaresi S; Department of Movement and Sports Sciences, Ghent University, 9000 Ghent, Belgium., Ahmadi S; Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa P.O. Box 7461686688, Iran., Ghasemian A; Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa P.O. Box 7461686688, Iran.
المصدر: Journal of functional biomaterials [J Funct Biomater] 2023 Sep 01; Vol. 14 (9). Date of Electronic Publication: 2023 Sep 01.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101570734 Publication Model: Electronic Cited Medium: Print ISSN: 2079-4983 (Print) Linking ISSN: 20794983 NLM ISO Abbreviation: J Funct Biomater Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel : MDPI AG
مستخلص: The gastrointestinal tract (GIT) environment has an intricate and complex nature, limiting drugs' stability, oral bioavailability, and adsorption. Additionally, due to the drugs' toxicity and side effects, renders are continuously seeking novel delivery systems. Lipid-based drug delivery vesicles have shown various loading capacities and high stability levels within the GIT. Indeed, most vesicular platforms fail to efficiently deliver drugs toward this route. Notably, the stability of vesicular constructs is different based on the different ingredients added. A low GIT stability of liposomes and niosomes and a low loading capacity of exosomes in drug delivery have been described in the literature. Bilosomes are nonionic, amphiphilic, flexible surfactant vehicles that contain bile salts for the improvement of drug and vaccine delivery. The bilosomes' stability and plasticity in the GIT facilitate the efficient carriage of drugs (such as antimicrobial, antiparasitic, and antifungal drugs), vaccines, and bioactive compounds to treat infectious agents. Considering the intricate and harsh nature of the GIT, bilosomal formulations of oral substances have a remarkably enhanced delivery efficiency, overcoming these conditions. This review aimed to evaluate the potential of bilosomes as drug delivery platforms for antimicrobial, antiviral, antifungal, and antiparasitic GIT-associated drugs and vaccines.
References: AAPS PharmSciTech. 2011 Mar;12(1):62-76. (PMID: 21174180)
J Pharm Pharm Sci. 2008;11(1):59-66. (PMID: 18445364)
Parasit Vectors. 2013 May 27;6:153. (PMID: 23711194)
Nanomedicine (Lond). 2020 Aug;15(19):1829-1841. (PMID: 32781886)
Gels. 2022 Oct 25;8(11):. (PMID: 36354595)
J Control Release. 2012 Oct 10;163(1):34-45. (PMID: 22698939)
J Agric Food Chem. 2013 Jul 3;61(26):6505-15. (PMID: 23758276)
Int J Nanomedicine. 2022 Oct 17;17:4861-4877. (PMID: 36262189)
Gels. 2022 Jan 07;8(1):. (PMID: 35049581)
Microb Pathog. 2022 May;166:105521. (PMID: 35436563)
Expert Opin Drug Deliv. 2019 Jun;16(6):563-566. (PMID: 31001991)
J Control Release. 2015 Jan 10;197:48-57. (PMID: 25449804)
Gastroenterol Clin North Am. 2001 Sep;30(3):797-815, x. (PMID: 11586558)
Nanomedicine. 2018 Oct;14(7):2023-2050. (PMID: 29944981)
Drug Deliv Transl Res. 2021 Apr;11(2):471-497. (PMID: 33528830)
Curr Top Med Chem. 2018;18(15):1287-1303. (PMID: 30277155)
Pharmaceuticals (Basel). 2022 Aug 24;15(9):. (PMID: 36145264)
Vaccine. 2009 Jun 2;27(27):3643-9. (PMID: 19464545)
Biochim Biophys Acta. 1978 Nov 1;543(4):508-22. (PMID: 718987)
Drug Discov Today. 2016 Jun;21(6):888-99. (PMID: 27038539)
Int J Pharm. 2010 Jan 29;385(1-2):47-52. (PMID: 19835938)
Microbiol Spectr. 2016 Jun;4(3):. (PMID: 27337464)
J Biomed Nanotechnol. 2014 Jun;10(6):932-47. (PMID: 24749389)
Nat Rev Dis Primers. 2017 Nov 09;3:17083. (PMID: 29119972)
Microbes Infect. 2019 Jun - Jul;21(5-6):237-245. (PMID: 31255676)
Eur J Pharm Sci. 2010 Oct 9;41(2):376-82. (PMID: 20633646)
J Infect Public Health. 2021 Dec;14(12):1750-1766. (PMID: 34756812)
Pharmaceutics. 2021 Aug 22;13(8):. (PMID: 34452273)
Cell Biochem Funct. 2022 Aug;40(6):623-635. (PMID: 35830577)
Gels. 2022 Feb 18;8(2):. (PMID: 35200513)
Pharmaceutics. 2020 Oct 27;12(11):. (PMID: 33120872)
Nat Rev Dis Primers. 2018 May 11;4:18026. (PMID: 29749387)
Pathogens. 2021 Oct 12;10(10):. (PMID: 34684258)
Vaccine. 2004 Jun 23;22(19):2425-9. (PMID: 15193405)
Adv Drug Deliv Rev. 2018 Jan 15;124:125-139. (PMID: 28882703)
J Control Release. 2019 Mar 28;298:202-212. (PMID: 30731152)
Recent Pat Nanotechnol. 2023;17(1):18-32. (PMID: 35227188)
Int J Pharm. 2014 Dec 30;477(1-2):390-8. (PMID: 25455781)
Curr Med Chem. 2022;29(25):4445-4473. (PMID: 35189798)
Adv Drug Deliv Rev. 2022 Mar;182:114097. (PMID: 34999121)
Amino Acids. 2021 Jan;53(1):73-88. (PMID: 33398527)
J Liposome Res. 2019 Mar;29(1):73-85. (PMID: 29355060)
Expert Opin Ther Pat. 2011 Apr;21(4):561-76. (PMID: 21413912)
Fungal Genet Biol. 2018 Feb;111:92-107. (PMID: 29102684)
ACS Appl Mater Interfaces. 2018 Mar 21;10(11):9315-9324. (PMID: 29484890)
J Biomed Nanotechnol. 2015 May;11(5):865-76. (PMID: 26349398)
Int J Med Microbiol. 2020 Jan;310(1):151358. (PMID: 31587966)
Eur J Med Chem. 2019 Feb 15;164:640-653. (PMID: 30640028)
Curr Opin Infect Dis. 2012 Aug;25(4):423-30. (PMID: 22766648)
Toxicology. 2004 May 20;198(1-3):229-38. (PMID: 15138046)
Gels. 2022 Jul 04;8(7):. (PMID: 35877503)
J Control Release. 2019 Mar 28;298:38-67. (PMID: 30738975)
PLoS One. 2013;8(2):e55536. (PMID: 23390538)
Food Res Int. 2021 Nov;149:110631. (PMID: 34600647)
J Drug Target. 2013 Apr;21(3):291-299. (PMID: 30952177)
Int J Pharm. 2019 Jun 10;564:410-425. (PMID: 31029657)
Int J Nanomedicine. 2020 Dec 08;15:9783-9798. (PMID: 33324052)
Biomacromolecules. 2021 Jan 11;22(1):24-56. (PMID: 32567846)
Br J Pharmacol. 2011 Sep;164(2b):820-7. (PMID: 21506959)
Polymers (Basel). 2022 Feb 25;14(5):. (PMID: 35267744)
Curr Drug Deliv. 2021;18(6):688-699. (PMID: 32807052)
Gastroenterol Clin North Am. 2021 Jun;50(2):243-260. (PMID: 34024440)
Drug Deliv. 2022 Dec;29(1):2694-2704. (PMID: 35975320)
Cancer Treat Res. 2014;161:237-51. (PMID: 24706227)
Methods. 2006 Feb;38(2):90-5. (PMID: 16414269)
Pharm Dev Technol. 2020 Feb;25(2):178-186. (PMID: 31631736)
Nanomedicine. 2014 Feb;10(2):431-40. (PMID: 24036099)
Drug Deliv. 2022 Dec;29(1):3035-3050. (PMID: 36120935)
Colloids Surf B Biointerfaces. 2021 Sep;205:111838. (PMID: 34022704)
Drug Deliv. 2021 Dec;28(1):2562-2573. (PMID: 34866534)
Nanomedicine. 2023 Apr;49:102662. (PMID: 36746272)
Colloids Surf B Biointerfaces. 2011 Apr 1;83(2):382-7. (PMID: 21215599)
J Photochem Photobiol B. 2023 Mar;240:112650. (PMID: 36701884)
فهرسة مساهمة: Keywords: bilosomes; drug delivery; gastrointestinal infections; vaccines
تواريخ الأحداث: Date Created: 20230927 Latest Revision: 20231003
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10531812
DOI: 10.3390/jfb14090453
PMID: 37754867
قاعدة البيانات: MEDLINE
الوصف
تدمد:2079-4983
DOI:10.3390/jfb14090453